Neal C Bradsher - Net Worth and Insider Trading
Neal C Bradsher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neal C Bradsher owns 5 companies in total, including Staar Surgical Co (STAA) , Lineage Cell Therapeutics Inc (LCTX) , and OncoCyte Corp (OCX) among others .
Click here to see the complete history of Neal C Bradsher’s form 4 insider trades.
Insider Ownership Summary of Neal C Bradsher
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STAA | Staar Surgical Co | 2007-06-21 | 10 percent owner |
| LCTX | Lineage Cell Therapeutics Inc | 2005-12-29 | 10 percent owner |
| OCX | OncoCyte Corp | 2016-08-29 | 10 percent owner |
| AST | Asterias Biotherapeutics Inc | 2019-03-08 | other: See Remarks Below |
| CMRO | Comarco Inc | 2017-09-15 | 10 percent owner |
Neal C Bradsher Trading Performance
Neal C Bradsher Ownership Network
Ownership Network List of Neal C Bradsher
Ownership Network Relation of Neal C Bradsher
Neal C Bradsher Owned Company Details
What does Staar Surgical Co do?
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.
Who are the key executives at Staar Surgical Co?
Neal C Bradsher is the 10 percent owner of Staar Surgical Co. Other key executives at Staar Surgical Co include Senior VP,Operations Robert Studholme , Chief Financial Officer Patrick F. Williams , and VP & Global Clinical & Medical Jon K. Hayashida .
Staar Surgical Co (STAA) Insider Trades Summary
Over the past 18 months, Neal C Bradsher made no insider transaction in Staar Surgical Co (STAA). Other recent insider transactions involving Staar Surgical Co (STAA) include a net sale of 51,636 shares made by James E Francese , a net sale of 210,000 shares made by Caren L Mason , and a net sale of 95,228 shares made by Hans-martin Blickensdoerfer .
In summary, during the past 3 months, insiders sold 0 shares of Staar Surgical Co (STAA) in total and bought 191,075 shares, with a net purchase of 191,075 shares. During the past 18 months, 461,670 shares of Staar Surgical Co (STAA) were sold and 191,075 shares were bought by its insiders, resulting in a net sale of 270,595 shares.
Staar Surgical Co (STAA)'s detailed insider trading history can be found in Insider Trading Tracker table.
NAS:STAA Insider Transactions
- 1
| Insider | Position | Date | Buy/Sell | Shares | Shares Owned | Trade Price($) | Trade Percentage(%) | Cost($1000) | Price change since trade(%) | Share ownership details | Filing Date |
|---|
- 1
What does Lineage Cell Therapeutics Inc do?
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, a oligodendrocyte progenitor cell therapy for acute spinal cord injuries and VAC2, a allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer. Its lead cell delivery clinical program is Renevia, an investigational medical device developed as an alternative for whole adipose tissue transfer procedures.
Who are the key executives at Lineage Cell Therapeutics Inc?
Neal C Bradsher is the 10 percent owner of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include Chief Financial Officer Jill Ann Howe , General Counsel/Secretary Samuel George A. Iii , and Chief Financial Officer Kevin Leon Cook .
Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary
Over the past 18 months, Neal C Bradsher made no insider transaction in Lineage Cell Therapeutics Inc (LCTX). Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 930,106 shares made by Broadwood Partners Lp , a net sale of 539,283 shares made by Gary S. Hogge , and a net purchase of 35,000 shares made by Dipti Amin .
In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 539,283 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 977,356 shares were bought by its insiders, resulting in a net purchase of 438,073 shares.
Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AMEX:LCTX Insider Transactions
- 1
| Insider | Position | Date | Buy/Sell | Shares | Shares Owned | Trade Price($) | Trade Percentage(%) | Cost($1000) | Price change since trade(%) | Share ownership details | Filing Date |
|---|
- 1
What does OncoCyte Corp do?
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests.
Who are the key executives at OncoCyte Corp?
Neal C Bradsher is the 10 percent owner of OncoCyte Corp. Other key executives at OncoCyte Corp include Interim CEO Josh Riggs , Controller & PAO James Yang Liu , and SVP & Finance & and Interim CFO Anish M. John .
OncoCyte Corp (OCX) Insider Trades Summary
Over the past 18 months, Neal C Bradsher made no insider transaction in OncoCyte Corp (OCX). Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 11,964,028 shares made by Pura Vida Investments, Llc , a net purchase of 415,000 shares made by Andrew Arno , and a net purchase of 100,000 shares made by John Peter Gutfreund .
In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 350,000 shares, with a net purchase of 350,000 shares. During the past 18 months, 107,514 shares of OncoCyte Corp (OCX) were sold and 18,844,166 shares were bought by its insiders, resulting in a net purchase of 18,736,652 shares.
OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
NAS:OCX Insider Transactions
- 1
| Insider | Position | Date | Buy/Sell | Shares | Shares Owned | Trade Price($) | Trade Percentage(%) | Cost($1000) | Price change since trade(%) | Share ownership details | Filing Date |
|---|
- 1
What does Asterias Biotherapeutics Inc do?
Asterias Biotherapeutics Inc is a biotechnology company engaged in developing and commercializing therapies in the fields of cell therapy and regenerative medicine. The company has two core technology platforms. The first is an immunotherapy platform to teach cancer patients immune systems to attack their tumors. The second is pluripotent stem cell platform. From immunotherapy platform it is developing AST-VAC1, an autologous product candidate for the treatment of acute myelogenous leukemia; and AST-VAC2, an allogeneic, cancer vaccine candidate designed to stimulate patient immune responses; and through pluripotent it has developed AST-OPC1, which is for the treatment of spinal cord injury, multiple sclerosis, and stroke. All the activities of the firm are operated through United States.
Who are the key executives at Asterias Biotherapeutics Inc?
Neal C Bradsher is the other: See Remarks Below of Asterias Biotherapeutics Inc. Other key executives at Asterias Biotherapeutics Inc include other: See Remarks Below Broadwood Partners Lp , other: See Remarks Below Broadwood Capital Inc , and director & President and CEO Michael H. Mulroy .
Asterias Biotherapeutics Inc (AST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Asterias Biotherapeutics Inc (AST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Asterias Biotherapeutics Inc (AST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Asterias Biotherapeutics Inc (AST)'s detailed insider trading history can be found in Insider Trading Tracker table.
AMEX:AST Insider Transactions
- 1
| Insider | Position | Date | Buy/Sell | Shares | Shares Owned | Trade Price($) | Trade Percentage(%) | Cost($1000) | Price change since trade(%) | Share ownership details | Filing Date |
|---|
- 1
What does Comarco Inc do?
Comarco Inc through its subsidiaries is engaged in developing numerous technologies in the field of power adapters and chargers for portable mobile devices such as laptop computers, tablets smartphones and more. The company is focused on realizing value from its ongoing intellectual property enforcement actions and other litigation. In addition, it also explores for opportunities to expand, protect, and monetize its patent portfolio, through the sale or licensing of the patent portfolio.
Who are the key executives at Comarco Inc?
Neal C Bradsher is the 10 percent owner of Comarco Inc. Other key executives at Comarco Inc include 10 percent owner Broadwood Partners Lp , 10 percent owner Broadwood Capital Inc , and VP & Chief Accounting Officer Alisha Charlton .
Comarco Inc (CMRO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Comarco Inc (CMRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Comarco Inc (CMRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Comarco Inc (CMRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
OTCPK:CMRO Insider Transactions
- 1
| Insider | Position | Date | Buy/Sell | Shares | Shares Owned | Trade Price($) | Trade Percentage(%) | Cost($1000) | Price change since trade(%) | Share ownership details | Filing Date |
|---|
- 1
Neal C Bradsher Mailing Address
Above is the net worth, insider trading, and ownership report for Neal C Bradsher. Currently GuruFocus does not have mailing address information for Neal C Bradsher.